Longevity & Aging · Metabolic & Cardiometabolic
testosterone therapy suppresses sperm production
In plain terms: Does testosterone therapy affect fertility?
Part of: 💊 Testosterone therapy (TRT)
Yes — and this is important and often overlooked. Taking testosterone shuts down your body's own testosterone and sperm production, frequently causing very low or zero sperm counts (it was actually studied as a male contraceptive). It's usually reversible after stopping, but recovery can take a year or more. Men who want children should not be on standard testosterone without protective co-treatment.
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
This is a **definitively established** and important harm: exogenous testosterone **suppresses the body's own testosterone and sperm production**, frequently causing severe low sperm counts or complete absence of sperm (azoospermia). It's so reliable that testosterone was studied as a **male contraceptive** (producing azoospermia in ~90-95% of men). The effect is usually **reversible** after stopp
The evidence (13)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Swerdloff RS et al. 1998 · J Clin Endocrinol Metab | RCT | supports | moderate | Trial (n=15): testosterone induced/maintained azoospermia or severe oligozoospermia in 14/15. |
| McBride JA, Coward RM 2016 · Asian J Androl | mechanism | supports | low | Review: TRT/AAS suppress the HPG axis and spermatogenesis; outlines gonadotropin/SERM/AI recovery strategies. |
| Oduwole OO et al. 2014 · Endocrinology | animal | supports | moderate | Mouse mechanistic study: exogenous testosterone dose-dependently suppresses spermatogenesis via HPG-axis and intratesticular-T suppression. |
| Rabijewski M 2016 · Ginekol Pol | mechanism | supports | low | Review: exogenous testosterone/AAS inhibit the HPG axis, reducing endogenous T and impairing spermatogenesis; hCG/SERM co-therapy advised. |
| Gu Y et al. 2009 · J Clin Endocrinol Metab | RCT | supports | high | Phase III contraceptive RCT (n=1045): IM testosterone undecanoate suppressed spermatogenesis to azoospermia/severe oligozoospermia in 95.2%; reversible in nearly all. |
| Page ST et al. 2006 · J Clin Endocrinol Metab | RCT | supports | moderate | RCT (n=44): testosterone gel + DMPA produced severe oligospermia in 90% within 24 weeks. |
| Ledesma BR et al. 2023 · Andrologia | observational | supports | moderate | Retrospective cohort (n=45): prior testosterone/AAS users with infertility had persistent severe oligospermia/azoospermia in >50% despite 6 months therapy. |
| Al Hashimi M et al. 2025 · Arab J Urol | mechanism | supports | low | Clinical-guide review: exogenous testosterone reduces intratesticular testosterone and impairs spermatogenesis, producing azoospermia. |
| Whitaker BM et al. 2021 · Transl Androl Urol | mechanism | supports | low | Review: exogenous testosterone is an underrecognized cause of male infertility; recovery achievable with SERMs/hCG/rFSH. |
| Handelsman DJ 1995 · Baillieres Clin Endocrinol Metab | mechanism | supports | moderate | Review of WHO trials: testosterone-induced azoospermia gives effective, reversible contraception for >=12 months. |
| Wallace EM et al. 1993 · J Clin Endocrinol Metab | observational | supports | moderate | Contraceptive-trial cohort (n=28): testosterone enanthate produced azoospermia in 17/28, oligozoospermia in 11/28; LH/FSH suppressed. |
| Rajmil O, Moreno-Sepulveda J 2023 · Andrologia | meta-analysis | supports | moderate | SR 13 studies: testosterone-based AAS impair spermatogenesis; reversible in most but may take over a year; supports gonadotropin/SERM recovery. |
| Anderson RA et al. 1997 · J Clin Endocrinol Metab | RCT | supports | moderate | RCT (n=33): weekly testosterone enanthate produced azoospermia in 18/33, oligozoospermia in 15/33; steroidogenesis suppressed <10%. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.